Literature DB >> 9139836

International incidence rates of invasive cervical cancer before cytological screening.

L Gustafsson1, J Pontén, R Bergström, H O Adami.   

Abstract

Huge differences in incidence rates of invasive cervical cancer occur among populations. These differences reflect the influences of both etiological environmental factors and removal of precursor lesions detected upon screening. The purposes of this article are (i) to describe similarities and differences in the shapes and magnitudes of age-specific incidence rates of invasive cervical cancer before screening had an effect, (ii) to provide baseline data for further global study of screening effects, and (iii) to provide baseline incidence data for the design of optimal screening programs. To eliminate the impact of screening effects, we have selected age-specific incidence rates from times when and from populations in which screening was insignificant. The selected rates were suitably scaled and compared regarding age at onset of increase in incidence, age at peak incidence, and rate of subsequent decline. Despite a 16-fold difference in incidence rates, all curves had the same basic structure, with an increase to a peak followed by a decline or a plateau. Although all populations but one had an onset around age 25, 7 European countries showed an earlier peak age (mean = 46 vs. 59) and a more rapid decline after the peak than most other populations. The common basic shape of the age-specific incidence curve, overall, suggests a relatively similar development of invasive cervical cancer in different populations. These results illustrate the underlying similarities in the markedly different age-specific incidence rates of invasive cervical cancer. They also provide a basis for studying screening effects and for optimizing screening programs in specific geographic areas.

Entities:  

Mesh:

Year:  1997        PMID: 9139836     DOI: 10.1002/(sici)1097-0215(19970410)71:2<159::aid-ijc6>3.0.co;2-#

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  40 in total

1.  Age-incidence relationships and time trends in cervical cancer in Sweden.

Authors:  K Hemminki; X Li; P Mutanen
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies.

Authors:  Julia C Gage; Kayode O Ajenifuja; Nicolas A Wentzensen; Akinfolarin C Adepiti; Claire Eklund; Mary Reilly; Martha Hutchinson; Sholom Wacholder; Joe Harford; Amr S Soliman; Robert D Burk; Mark Schiffman
Journal:  Int J Cancer       Date:  2011-08-05       Impact factor: 7.396

3.  Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations.

Authors:  Carole Fakhry; Barbara T Rosenthal; Douglas P Clark; Maura L Gillison
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-11

4.  Cervical Pathology Following HPV Vaccination in Greece: A 10-year HeCPA Observational Cohort Study.

Authors:  Evangelos Paraskevaidis; Antonios Athanasiou; Maria Paraskevaidi; Evripidis Bilirakis; Georgios Galazios; Emmanuel Kontomanolis; Konstantinos Dinas; Aristotelis Loufopoulos; Maria Nasioutziki; Ioannis Kalogiannidis; Apostolos Athanasiadis; Alexios Papanikolaou; Anastasia Vatopoulou; Gregorios Grimbizis; Dimitrios Tsolakidis; Alexandros Daponte; George Valasoulis; Stella Gritzeli; Georgios Michail; Georgios Adonakis; Minas Paschopoulos; Orestis Tsonis; Maria-Eugenia Anaforidou; Anna Batistatou; Maria Kyrgiou
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 5.  Human papillomavirus testing in the prevention of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen; Sholom Wacholder; Walter Kinney; Julia C Gage; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2011-01-31       Impact factor: 13.506

6.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Authors:  Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers
Journal:  CA Cancer J Clin       Date:  2012-03-14       Impact factor: 508.702

7.  Attitudes and knowledge of Georgian physicians regarding cervical cancer prevention, 2010.

Authors:  Robert A Bednarczyk; Maia Butsashvili; George Kamkamidze; Maia Kajaia; Louise-Anne McNutt
Journal:  Int J Gynaecol Obstet       Date:  2013-03-14       Impact factor: 3.561

Review 8.  Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha
Journal:  BMC Infect Dis       Date:  2009-07-29       Impact factor: 3.090

9.  Incidence of cervical cancer after several negative smear results by age 50: prospective observational study.

Authors:  Matejka Rebolj; Marjolein van Ballegooijen; Elsebeth Lynge; Caspar Looman; Marie-Louise Essink-Bot; Rob Boer; Dik Habbema
Journal:  BMJ       Date:  2009-04-24

10.  Model for assessing human papillomavirus vaccination strategies.

Authors:  Elamin H Elbasha; Erik J Dasbach; Ralph P Insinga
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.